SEC Tracker
Get the app

Response Biomedical

Response Biomedical: quarterly report for the quarter ended Jun 30, 2016

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Quarter ended Jun 30, 2016: net loss $1.3M

From the 10-Q 0001437749-16-037492, as tagged in its XBRL.

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Response Biomedical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.